Form D — Gilgamesh Pharma Inc.
0002107396-26-000002 · filed Feb 4, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $6,090,946
- Total sold
- $6,090,946
- Minimum investment
- $27,597
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Gilgamesh Pharma Inc.
- CIK
- 2107396
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 113 UNIVERSITY PLACE, SUITE 1019
NEW YORK, NY 10003 - Phone
- 929-723-4861
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jonathan Sporn · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
Andrew Kruegel · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
Amy Kruse · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Zia Huque · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Phil Skolnick · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Robert Berman · DirectorNEW YORK, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗